Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928482 · ClinicalTrials.gov registry record · NA

Responses to Backward Walking Training Post-Stroke

A NA study of Stroke, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
2
Study locations

NCT04928482: Recruiting NA study of Stroke, sponsored by VA Office of Research and Development.

NCT04928482 is a NA study of Stroke that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 48 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04928482, a NA study of Stroke, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
2
Study locations

Study Summary

Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. The investigators have previously established the effectiveness of a backward walking training program to improve gait and balance in post-stroke Veterans. To best serve Veterans in this era of personalized medicine, there is a current need to determine the appropriate training dose as well as which post-stroke Veterans would most benefit. This study addresses both needs as it will 1) test responses to two different doses (18 vs. 27 sessions) of backward walking training and 2) assess brain activity, measured by magnetic resonance imaging, before and after training intervention to determine its ability to predict rehabilitation response as well as brain mechanisms of behavioral change.

Primary Outcome

Gait speed will be measured with the 10-Meter Walk Test. Individuals will be given a 3 meter warm-up distance for walking, preceding the 10 meter distance and 3 meters beyond the 10 meters to continue walking. The time that it takes to traverse the 10 meters at the subject's usual pace will be recorded.

Conditions Studied

Interventions

  • BEHAVIORAL Backward Walking Training

Study Locations (2)

Florida

  • North Florida/South Georgia Veterans Health System, Gainesville, FL - Gainesville
  • Brooks Rehabilitation - Jacksonville

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2021-11-08
Est. Completion 2026-07-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT04928482 shows while recruiting

NCT04928482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Backward Walking Training is the first listed.

NCT04928482 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04928482 about?

NCT04928482 is a clinical study titled "Responses to Backward Walking Training Post-Stroke". Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. The investigators have previously established the effectivenes...

What is the current status of trial NCT04928482?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2021-11-08. Estimated completion is 2026-07-31.

What conditions does trial NCT04928482 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04928482?

The interventions under investigation include: Backward Walking Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04928482?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04928482 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04928482's enrollment target sits among peer trials

48 247th of 454 higher than 207 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04928482, the US trial registry maintained by the National Library of Medicine. NCT04928482 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.